NCT00487305View on ClinicalTrials.gov

Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
Follicular Lymphoma
Interventions
BIOLOGICAL

Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells

Dose will vary depending upon number of cells collected and when the participant is enrolled on the study: the vaccine is given as an injection under the skin once weekly for 3 weeks then every other week for 3 vaccines.

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT00487305 - Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma | Biotech Hunter | Biotech Hunter